PROCEPT BioRobotics Shareholders With Over $100K Loss Urged to Lead Securities Fraud Lawsuit
Rosen Law Firm is urging PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shareholders who suffered losses exceeding $100,000 to lead a securities fraud lawsuit. The deadline for action is in September.
NEW YORK – October 2026 – PR Newswire
Rosen Law Firm, an international investor rights law firm, is reminding purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock who experienced losses exceeding $100,000 of the opportunity to lead a securities fraud lawsuit.
The lawsuit concerns the company's common stock purchased between February 28, 2024, and February 25, 2026. PROCEPT BioRobotics focuses on robotic-assisted solutions for surgical procedures.
The law firm encourages potential lead plaintiffs to contact them by the September deadline to discuss their rights and options. The specific date for this deadline requires further clarification.
Rosen Law Firm is investigating claims that PROCEPT BioRobotics may have issued misleading statements or failed to disclose crucial information to investors, potentially impacting the stock's market value. Such actions could constitute violations of securities laws.